| A manually curated network of the PML nuclear body interactome reveals an important role for PML-NBs in SUMOylation dynamics E Van Damme, K Laukens, TH Dang, X Van Ostade International journal of biological sciences 6 (1), 51, 2010 | 266 | 2010 |
| High-throughput analysis of human cytomegalovirus genome diversity highlights the widespread occurrence of gene-disrupting mutations and pervasive recombination S Sijmons, K Thys, MM Ngwese, E Van Damme, J Dvorak, M Van Loock, ... Journal of virology 89 (15), 7673-7695, 2015 | 176 | 2015 |
| Lack of antiviral activity of darunavir against SARS-CoV-2 S De Meyer, D Bojkova, J Cinatl, E Van Damme, C Buyck, M Van Loock, ... International Journal of Infectious Diseases 97, 7-10, 2020 | 148 | 2020 |
| Capsid assembly modulators have a dual mechanism of action in primary human hepatocytes infected with hepatitis B virus JM Berke, P Dehertogh, K Vergauwen, E Van Damme, W Mostmans, ... Antimicrobial agents and chemotherapy 61 (8), 10.1128/aac. 00560-17, 2017 | 135 | 2017 |
| Functional annotation of human cytomegalovirus gene products: an update E Van Damme, M Van Loock Frontiers in microbiology 5, 85775, 2014 | 93 | 2014 |
| Human cytomegalovirus miR-UL112-1 promotes the down-regulation of viral immediate early-gene expression during latency to prevent T-cell recognition of latently infected cells B Lau, E Poole, E Van Damme, L Bunkens, M Sowash, H King, E Murphy, ... Journal of General Virology 97 (9), 2387-2398, 2016 | 53 | 2016 |
| Glucocorticosteroids trigger reactivation of human cytomegalovirus from latently infected myeloid cells and increase the risk for HCMV infection in D+ R+ liver transplant patients E Van Damme, S Sauviller, B Lau, B Kesteleyn, P Griffiths, A Burroughs, ... Journal of General Virology 96 (1), 131-143, 2015 | 42 | 2015 |
| In vitro activity of itraconazole against SARS‐CoV‐2 E Van Damme, S De Meyer, D Bojkova, S Ciesek, J Cinatl, S De Jonghe, ... Journal of medical virology 93 (7), 4454-4460, 2021 | 35 | 2021 |
| A method enabling high-throughput sequencing of human cytomegalovirus complete genomes from clinical isolates S Sijmons, K Thys, M Corthout, E Van Damme, M Van Loock, S Bollen, ... PLoS One 9 (4), e95501, 2014 | 27 | 2014 |
| Crosstalk between viruses and PML nuclear bodies: a network-based approach E Van Damme, X Van Ostade Front Biosci 17, 2910-2920, 2011 | 19 | 2011 |
| The hepatitis B virus interactome: a comprehensive overview E Van Damme, J Vanhove, B Severyn, L Verschueren, F Pauwels Frontiers in Microbiology 12, 724877, 2021 | 18 | 2021 |
| Development and optimization of a high‐throughput screening assay for in vitro anti‐SARS‐CoV‐2 activity: Evaluation of 5676 Phase 1 Passed Structures W Chiu, L Verschueren, C Van den Eynde, C Buyck, S De Meyer, ... Journal of medical virology 94 (7), 3101-3111, 2022 | 12 | 2022 |
| HCMV displays a unique transcriptome of immunomodulatory genes in primary monocyte-derived cell types E Van Damme, K Thys, M Tuefferd, C Van Hove, J Aerssens, ... PLoS One 11 (10), e0164843, 2016 | 12 | 2016 |
| Capsid assembly modulator JNJ-56136379 prevents de novo infection of primary human hepatocytes with hepatitis B virus. JM Berke, P Dehertogh, K Vergauwen, E van Damme, P Raboisson, ... Hepatology 63 (1 SUPP), 124A-124A, 2016 | 12 | 2016 |
| A flexible, image-based, high-throughput platform encompassing in-depth cell profiling to identify broad-spectrum coronavirus antivirals with limited off-target effects J Doijen, I Heo, K Temmerman, P Vermeulen, A Diels, S Jaensch, ... Antiviral Research 222, 105789, 2024 | | 2024 |
| In Vitro Activity of Itraconazole Against SARS-CoV-2 E Van Damme, S De Meyer, D Bojkova, S Ciesek, J Cinatl, S De Jonghe, ... bioRxiv, 2020 | | 2020 |
| A Method Enabling High-Throughput Sequencing of Human Cytomegalovirus S Sijmons, K Thys, M Corthout, E Van Damme, M Van Loock | | 2014 |
| A Fluorescence-Based High-Throughput Screening Assay for Identifying Human Cytomegalovirus Inhibitors C Van den Eynde, E Van Damme, T Ivens, EY Gong Antiviral Methods and Protocols, 327-334, 2013 | | 2013 |
| Full genome characterization of human cytomegalovirus in high-throughput S Sijmons, K Thys, M Corthout, E Van Damme, M Van Loock, S Bollen, ... International Bioinformatics Workshop on Virus Evolution and Molecular …, 2013 | | 2013 |
| Full genome sequencing reveals variation in HCMV coding capacity S Sijmons, K Thys, M Corthout, E Van Damme, M Van Loock, S Bollen, ... International CMV/BetaHerpesvirus Workshop, Date: 2012/10/29-2012/11/02 …, 2012 | | 2012 |
Steven SijmonsOregon Health & Science UniversityVerified email at ohsu.edu
